Abstract -This review considers several neurochemical characteristics or trait markers that may be related to a genetic vulnerability to alcoholism. These potential neurochemical markers of alcoholism vulnerability include indices of activity of five neurotransmitter systems, namely γ-aminobutyric acid, serotonin, dopamine, noradrenaline and β-endorphin. This review evaluates whether potential abnormalities in these neurochemical indices, as assessed in alcoholics and in the children of alcoholics, meet three criteria for the identification of a vulnerability marker of alcoholism: (1) heritable; (2) associated with alcoholism in the general population; (3) state independent. It is concluded that, at present, indices of increased baseline activity of the serotonin transporter in platelets and of increased responsiveness of the pituitary β-endorphin system may fulfil each of these three criteria. Additional research efforts should be devoted to the evaluation of trait marker properties of neurochemical indices in individuals at high risk for alcoholism.
INTRODUCTION
Alcoholism is generally assumed to be a multifactorial disease, in which polygenic influences and environmental influences interact (Goldman, 1995) . This conceptualization of alcoholism has been inferred from adoption studies (Goodwin et al., 1973; Bohman et al., 1981; Cadoret et al., 1985; Cloninger et al., 1985) and twin studies (Romanov et al., 1991; Kendler et al., 1994 Kendler et al., , 1997 Reed et al., 1996; Treu et al., 1996; Heath et al., 1997) . The question arises as to what is inherited in alcoholism? Over the past two decades, research on so-called phenotypic trait or vulnerability markers of alcoholism has attempted to shed light on this basic issue. This research has focused on various behavioural, electrophysiological, and neurochemical characteristics that may be related to alcoholism vulnerability (Begleiter and Porjesz, 1988; Farren and Tipton, 1999; Schuckit, 1999; Van der Stelt, 1999) . This review evaluates whether abnormalities in certain neurochemical indices, as assessed in alcoholics and in the children of alcoholics (COA), may serve as neurochemical markers of alcoholism vulnerability.
A trait or vulnerability marker may be defined as a 'heritable trait, associated with a causative pathophysiological factor in an inherited disease' . As opposed to a diagnostic marker, a vulnerability or pathophysiological marker is not required to have high sensitivity or high specificity to a certain clinical disorder (Nurnberger, 1992) . While sensitivity and specificity are not critical criteria, it has been proposed that a certain behavioural or biological trait should meet at least three basic criteria in order to be considered as a trait marker : (1) heritable; (2) associated with the disease in the general population; (3) state independent. The reason for these requirements is to prevent false-positive or false-negative conclusions about the validity of a certain characteristic as a trait marker due to certain conditions, particularly population stratification, which may obscure the relation between a marker and a clinical syndrome. Family studies are required to determine whether the trait marker co-segregates with alcoholism within families, since all members of a family are part of the same population. However, there is as yet little information on the cosegregation of neurochemical markers with alcoholism in affected families.
This review evaluates whether abnormalities in certain neurochemical indices, as assessed in alcoholics and in COA, meet the three above-mentioned criteria for the identification of a trait marker of alcoholism. Thus, the issue is addressed whether a certain neurochemical abnormality is associated with alcoholism, or with a given subtype of alcoholism, in the general population. To clarify this issue, studies are reviewed in which measures of neurochemical activity are compared between alcoholics and unrelated non-alcoholic controls. In addition, to evaluate whether a certain neurochemical abnormality is heritable, this review focuses on twin and adoption studies to find out whether the abnormality is mediated largely by genetic, as opposed to environmental, factors. Finally, to evaluate whether the neurochemical abnormality is state independent, that is, not reflecting the current state of alcoholism but present throughout an individual's lifetime, studies are reviewed in which the neurochemical measure of interest is compared between individuals at high risk for alcoholism and low-risk controls. As opposed to this high-risk research, studies of (abstinent) alcoholics cannot distinguish between state and trait markers of alcoholism. Even after many years of abstinence from alcohol, the prolonged abuse of alcohol may have had long-term neurotoxic effects, potentially affecting neurochemical trait markers in abstinent alcoholics.
This review will focus on indices of neurochemical markers. These are indices of changes in neurotransmitter systems that are studied as trait markers in alcoholism, in accordance with the three above-mentioned criteria. The state effect of alcohol on changes in neurotransmission has been widely studied within neurotransmitter systems. It has, for example, been the main approach adopted in studies of the N-methyl-D-aspartate receptor of the glutamatergic system. However, this review focuses on indices of changes within five neurotransmitter systems that may have a trait effect on alcoholism. This includes the following neurotransmitters: (1) γ-aminobutyric acid (GABA) (Frye and Breese, 1982; Koob et al., 1986) ; (2) 5-hydroxytryptamine (serotonin; importantly, the impaired functioning of CNS serotonin may result in diminished impulse control, a neurobiological feature of type II alcoholism) (Linnoila et al., 1983; Cloninger, 1987) ; (3) dopamine (Gessa et al., 1985; Imperato and Di Chiara, 1986; Wise and Bozarth, 1987) ; (4) noradrenaline (Cloninger, 1994) ; (5) β-endorphin. This last topic is the subject of two contradictory hypotheses. The endorphin compensation or deficiency hypothesis states that alcohol use compensates for a predisposed or acquired deficiency of endorphinergic receptor activity (Blum, 1983; Volpicelli et al., 1985; Erickson, 1990) , whereas the opioid surfeit hypothesis states that alcohol use is increased by a surfeit of opioidergic receptor activity, rather than a deficit (Reid and Hunter, 1984; Hubbell et al., 1986; Reid et al., 1991) . Both hypotheses are equally applicable to other neurotransmitter systems. G-proteins and adenylyl cyclase (or any other secondary messenger systems) have not been included in this review as they are not neurotransmitters.
GENERAL PRINCIPLES AND OBSERVATIONS FROM ANIMAL STUDIES
This review focuses on central and peripheral indices of activity of the five neurotransmitter systems, GABA, serotonin, dopamine, noradrenaline and β-endorphin. On the basis of findings mainly from animal research, each of these neurotransmitter systems has been implicated in the aetiology and pathophysiology of alcoholism. The requisite theoretical background was provided by animal studies carried out in the 1950s, which reported that changes in neurotransmission in rat brains led to addiction-related behaviour. Olds and Milner (1954) found that intracranial stimulation of the hypothalamus and associated structures can act to reinforce operant conditioning. Brain stimulation itself activated systems that were normally activated by a reinforcing stimulus, such as feeding or drinking (Deutsch and Howarth, 1963) . Brain selfstimulation (using electrodes placed in the vicinity of dopaminergic neurons) was accompanied by locomotor activation and positive reinforcement (Routtenberg, 1978) . Similarly, it has been hypothesized that euphoria and drugseeking behaviour (whether induced by alcohol or other commonly abused substances) arise from activation of the mesolimbic dopaminergic reward pathways of the brain (Gessa et al., 1985; Imperato and Di Chiara, 1986; Wise and Rompre, 1989) . Endogenous opioids were also reported to be involved in reward processes during brain self-stimulation (Schaefer, 1988) . The intracerebroventricular self-administration of β-endorphin in rats has demonstrated that this substance acts as an endogenous positive reinforcer of behaviour. Thus, it might intrinsically control behaviour such as the selfadministration of addictive drugs (Van Ree et al., 1979) . In addition, the opioid antagonist naltrexone blocks the release of dopamine at the level of the nucleus accumbens, which follows alcohol administration (Benjamin et al., 1993) . However, the results of animal and human studies suggest that the effects of alcohol consumption are not restricted to dopamine and endogenous opioids. Alcohol consumption may also affect several other brain neurotransmitters, including noradrenaline (Ahlenius et al., 1973; Brown and Amit, 1982) , serotonin Murphy et al., 1988) and GABA (Hwang et al., 1990; McBride et al., 1990) . As alcohol seems to activate most neurotransmitter pathways, the question arises whether vulnerability to alcoholism is associated with a pre-existing deficit within neurotransmitter pathways.
TYPES OF HUMAN STUDIES
Human research on neurochemical vulnerability markers of alcoholism mainly consists of those at baseline, studies assessing neurochemical indices following a pharmacological challenge, and post-mortem studies. Baseline studies attempt to identify individual variations in the trait marker, in the absence of any interference from alcohol. Challenge studies often attempt to identify individual variations of the trait marker after alcohol intake, while some studies use challenge drugs other than alcohol (acting on one or more of the five neurotransmitter systems under review). This is because any individual variation in sensitivity to the effects of alcohol (or other challenge drugs) might be associated with a variation in the risk of alcoholism (Schuckit et al., 1983; Schuckit and Smith, 1996) . Generally, post-mortem studies simply reveal that alcohol has a toxic effect on neurotransmitter systems. The reported results do not usually draw a distinction between the trait and the state effects of alcohol. Baseline and challenge studies are not only performed in alcoholics, but also in high-risk individuals, such as COA. COA represent a unique, high-risk group in studies of the state independence of the trait marker. This is because they have a heightened risk of alcoholism, and because the youngest groups do not generally consume alcohol on a regular basis (Eskay and Linnoila, 1991; Hill et al., 1991; Sher et al., 1991) . This review includes neurochemical-trait-marker studies that investigated changes in the levels of neurotransmitters (or their metabolites) in cerebrospinal fluid (CSF) or plasma, and changes in the number, activity and affinity of receptors in the brain. Also included in this review are studies performed on the brain either directly or indirectly (by means of peripheral assessments). There is still some doubt concerning the degree of correspondence between the latter measurements and neurotransmitter activity in the central regions. However, there are problems associated with making some of the abovementioned measurements in neurobiological studies on humans. For example, it may be ethically problematic to subject one particular group of high-risk individuals -the young COAto invasive or extensive examinations. This is because such examinations include investigations of the CSF, alcohol challenge tests, and various brain-imaging techniques that use radioactive substances. Neurobiological research in high-risk groups, on the other hand, can be carried out with the aid of peripheral blood samples, using platelets for example (Ratsma et al., 1999) .
In this review, results from challenge studies, baseline studies, and post-mortem studies of alcoholics and their children are evaluated to determine whether certain neurochemical abnormalities meet the three criteria outlined above for the identification of a vulnerability marker of alcoholism.
γ-AMINOBUTYRIC ACID

Pharmacological properties
GABA acts on the GABA A receptor, which is a transmittergated chloride channel. GABA A receptors are composed of three subunits: α, β, and γ. Fourteen variants have been identified to date, six α variants, three β variants, three γ variants and two δ variants. Alcohol and benzodiazepines act on the γ subunit of the GABA A receptor (Suzdak et al., 1986) , whereas GABA acts on the α subunit. Changes in the subunit expression of GABA A receptors are reflected in the pharmacological properties of the receptors (Levitan et al., 1988) . By contrast, GABA B receptor is a G-protein-coupled receptor without a benzodiazepine binding site.
Research findings
In the post-mortem frontal cortex, expression of mRNA for the GABA A receptor's α 1 and β 3 subunits is higher in alcoholics than in controls (Lewohl et al., 1997; Mitsuyama et al., 1998) . These findings are consistent with the results of two post-mortem studies, in which non-cirrhotic alcoholics were found to have more GABA receptors in their cerebral cortex and superior frontal gyrus than the control subjects (Tran et al., 1981; Dodd et al., 1992) . Brain imaging studies using single-photon emission computed tomography (SPECT) (Abi-Dargham et al., 1998; Lingford-Hughes et al., 1998) have found that, in alcoholics and type II alcoholics, the benzodiazepine receptor distribution volume in the anterior cingulate, the prefrontal, frontal, parietal and temporal cortices and in the cerebellum was reduced, relative to controls. Similarly, challenge studies using positron emission tomography (PET) revealed the existence of a blunted glucose utilization response to lorazepam in alcoholics (in the basal ganglia and thalamus) and in COA (in the cerebellum), relative to controls (Volkow et al., 1993 (Volkow et al., , 1995 . These SPECT and PET findings indicate abnormalities in brain GABAbenzodiazepine receptor reactivity in alcoholics and individuals at high risk for alcoholism. Finally, in alcoholics in the early phase of abstinence and those who had been abstinent for 1-2 years, a challenge with γ-hydroxybutyric acid (a GABA agonist) showed a blunted growth-hormone (GH) response, relative to controls Coiro, 1995, 1997) . This also may represent reduced GABA neurotransmitter reactivity.
In apparent contrast to these findings of blunted, postchallenge GABA responses in alcoholics and COA, one study has reported that GABA plasma levels of COA increased much more in response to alcohol than was the case in controls (Moss et al., 1990) . Another study, however, found no significant difference in the GABA plasma levels between COA and controls following a diazepam challenge .
A twin study (Berrettini et al., 1982) showed that the interindividual differences in baseline plasma level of GABA are heritable. Abstinent adult male alcoholics were found to have a lower baseline plasma GABA level than non-alcoholics (Coffman and Petty, 1985; Petty et al., 1993) . In COA, one study showed similarly that COA had lower baseline plasma levels of GABA than controls (Moss et al., 1990) , but another study found no significant group difference . The young adult COA in the latter study were selected for having no history of alcohol or drug abuse at ages 18-25 years. This may mean that they were at reduced risk of an early onset of alcoholism, which, in turn, may have biased the sample.
In conclusion, a lower baseline plasma level of GABA seems to fulfil two criteria for the identification of a vulnerability marker of alcoholism. Inter-individual differences in measures of baseline plasma level of GABA appear to be heritable and alcoholics show reduced levels of GABA in their plasma (see Tables 1 and 2 ). It remains to be determined, however, whether a lower baseline plasma level of GABA in alcoholics represents a state marker or a trait marker that can also be detected in individuals at high risk for alcoholism. Similarly, measures of decreased GABA receptor responsiveness appear to fulfil two trait marker criteria. Decreased GABA receptor responsiveness seems to characterize both alcoholics and their children. It remains to be clarified whether this characteristic is genetically mediated, though.
5-HYDROXYTRYPTAMINE
Pharmacological properties
5-Hydroxytryptamine (5-HT, serotonin) acts on 15 known subtypes of 5-HT receptors, which fall into four structural and functional 'families' of receptors. Three types (5-HT 1 , 5-HT 2 and 5-HT 4 ) are coupled to G-proteins, whereas the 5-HT 3 receptor acts as a 5-HT-gated ion channel. Although the genes of three other types (5-HT 5 , 5-HT 6 and 5-HT 7 ) have been cloned, their physiological functions are as yet unknown. The 5-HT transporter is located in the serotonergic axon terminals, where it terminates 5-HT action in the synapse, and in platelet membranes, where it takes up 5-HT from the blood (Blakely et al., 1991) . The synthesis of serotonin is influenced by the amount of the precursor tryptophan in the brain. In order to gain entry to the brain, tryptophan has to compete with other amino acids. The extent to which tryptophan in the blood circulation is available to the brain may be decreased in alcoholics with a positive family history (see review by Badawy, 1999) . The concentration of 5-hydroxyindol-3-yl-acetic acid (5-HIAA; the major metabolite of serotonin) in CSF seems to reflect central serotonergic activity (Banki and Molnar, 1981) .
Research findings
Post-mortem studies of brain tissue from alcoholics have revealed reduced 5-HT transporter binding in the hippocampus (Gross-Isseroff and Biegon, 1988; Chen et al., 1991) . Similarly, binding was found to be reduced in the 5-HT 1A receptors of alcohol consumers relative to those of subjects who did not (Dillon et al., 1991) .
Following a challenge with a mixed serotonin partial agonist, m-chlorophenylpiperazine (mCPP), the adrenocorticotropic hormone response and the serotonergic activation in the basal ganglia circuits (involving orbital and prefrontal cortices) were found to be lower in alcoholics, than in nonalcoholics (Krystal et al., 1994; George et al., 1997; Hommer et al., 1997) . These findings were reflected by a decrease in the brain's utilization of glucose, as shown by PET. This suggests that 5-HT 2C receptors in alcoholics exhibit reduced sensitivity. Other studies reported challenges in which GH, prolactin and cortisol exhibited blunted responses to fenfluramine (releasing serotonin as an indirect agonist), mCPP and sumatriptan (a 5-HT 1D receptor agonist). The subjects in question were active alcoholics and abstaining alcoholics who had not used alcohol for 1-2 years (Balldin et al., 1994; Krystal et al., 1996; Vescovi and Coiro, 1997) . Conversely, an elevated cortisol response was reported after a challenge with fenfluramine in a high-risk group of attentiondeficit hyperactivity disorder (ADHD) boys, versus ADHD boys with a low risk of alcoholism; the assessed degree of risk was based on the presence or absence of parental alcoholism (Schulz et al., 1998) .
The results of a study using SPECT showed a reduction in brain-stem serotonin transporters in alcoholics (after 3-5 weeks of abstinence) relative to controls (Heinz et al., 1998) . A decrease in alcoholism-related serotonin transport was associated with a decrease in the 5-HT content of platelets in alcoholics (Banki, 1978) . It also corresponded to a decrease NEUROCHEMICAL MARKERS OF ALCOHOLISM VULNERABILITY 525 GABA, γ-aminobutyric acid; 5-HT, serotonin or 5-hydroxytryptamine; CSF, cerebrospinal fluid; HVA, homovanillic acid. (Tran et al., 1981; Coiro, 1995, and cerebellum (Abi-Dargham Dodd et al., 1992) 1997) et al., 1998) COA vs controls:
Alcoholics vs controls: Decreased glucose utilization Decreased GABA plasma response to agonist lorazepam in levels (Coffman and Petty, cerebellum (Volkow et al., 1995) 1985; Petty et al., 1993) 
COA vs controls:
COA vs controls: Increased plasma GABA levels Decreased plasma GABA after alcohol (Moss et al., 1990) levels (Moss et al., 1990 ) COA vs controls:
COA vs controls: Indifferent plasma GABA Indifferent plasma GABA levels after agonist diazepam levels (relative to controls) in the uptake of [ 3 H]5-HT by platelets in alcoholics undergoing a 2-week period of detoxification (Kent et al., 1985) . A twin study found that 5-HT uptake in blood platelets is moderated by genetic factors (Meltzer and Arora, 1988) .
Alcoholics who had abstained from alcohol for periods of 1 month to 22 years (and their children) were found to have a higher [ 3 H]5-HT platelet uptake than controls (Ernouf et al., 1993) . This is contrary to the findings in active alcoholics and in those who had only recently started practising abstinence. In addition, male COA were found to have a higher V max (capacity) of platelet serotonin uptake than controls (Rausch et al., 1991) . As a result, it was suggested that an increase (rather than a decrease) in platelet serotonin transport was a trait marker for alcoholism (Ernouf et al., 1993) . It is important to note that earlyonset alcoholics exhibit higher platelet-serotonin-transporter activity than late-onset alcoholics (Javors et al., 2000) .
With regard to 5-HIAA, the levels of this metabolite in CSF taken from abstinent alcoholics of both sexes were shown to be lower than in controls (Ballenger et al., 1979; Banki, 1981; Borg et al., 1985) . Alcoholic impulsive offenders had lower CSF 5-HIAA levels than alcoholic non-impulsive offenders, whereas the controls had intermediate levels (Virkkunen et al., 1994) . Early-onset alcoholics had lower 5-HIAA levels than late-onset alcoholics (Fils-Aime et al., 1996) . This was consistent with studies demonstrating low precursor serotonin availability in early-onset alcoholism (Buydens-Branchey et al., 1989) . CSF 5-HIAA concentrations might be a staterelated phenomenon, since essential dietary fatty acids could cause changes in CSF 5-HIAA concentrations (Hibbeln et al., 1998) . However, an animal study of CSF 5-HIAA levels in monkeys revealed a high degree of intra-individual stability (Raleigh et al., 1992) . The above-mentioned CSF 5-HIAA studies, which were only performed in alcoholics, were consistent with the hypothesis that decreased CSF 5-HIAA levels represent a central serotonergic deficit in a subgroup of earlyonset male alcoholics (Linnoila et al., 1983) .
In conclusion, the inter-individual differences in baseline serotonin transporter activity in platelets seem to be heritable. There are also indications that baseline serotonin transporter activity is elevated in COA and in alcoholics who have been abstinent for a protracted period of time. The measurement of increased baseline serotonin transporter activity in platelets would therefore appear to fulfil three of the criteria for trait markers for alcoholism. Challenge studies of serotonin receptor responsiveness have shown (albeit inconsistently) a decreased 5-HT response in alcoholics. There is also one report of an elevated response in COA, thus one criterion may have been met (Tables 1 and 3 ). Chen et al., 1991) response to partial 5-HT agonist 1998) mCPP (Hommer et al., 1997) 
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Alcoholics vs controls: Decreased prolactin and cortisol Increased platelet serotonin uptake response to serotonin (Balldin (Ernouf et al., 1993 Krystal et al., 1996) , (long-term abstinence) Alcoholics vs controls: COA vs controls: Decreased growth hormone Increased platelet serotonin uptake response to 5-HT 1D receptor (Rausch et al., 1991 ; agonist sumatriptan (Vescovi Ernouf et al., 1993) (Ballenger et al., 1979; Banki, 1981; Borg et al., 1985) Early-onset vs late-onset alcoholics: Decreased CSF 5-HIAA level (Fils-Aime et al., 1996) Impulsive vs non-impulsive alcoholics: Decreased CSF 5-HIAA levels (Virkkunen et al., 1994) 5-HT, serotonin or 5-hydroxytryptamine; ACTH, adrenocorticotropic hormone; mCPP, m-chlorophenylpiperazine; SPECT, single-photon emission computed tomography; COA, children of alcoholics; ADHD, attention-deficit hyperactivity disorder; CSF, cerebrospinal fluid; 5-HIAA, 5-hydroxyindol-3-yl-acetic acid.
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DOPAMINE
Pharmacological properties
Dopamine acts on at least five dopamine receptors, which are divided into two major groups: (1) 
Research findings
In one challenge study, male alcoholics who had been abstinent for a period of 7 years exhibited reduced postsynapticdopamine-receptor sensitivity relative to controls. This was expressed as a reduced maximum GH response to the agonist apomorphine (Balldin et al., 1992) . This report was consistent with the reduction in GH response (relative to controls) seen in alcoholics who had been abstaining from alcohol for periods ranging from 8 days to 6 months (Dettling et al., 1995) . However, an earlier study showed that, after a withdrawal period of 4-7 days, alcoholics exhibited an elevated GH response to dopamine infusion, whereas their GH responses to apomorphine were similar to those of controls (Annunziato et al., 1983; Balldin et al., 1985) . The dopamine receptor involved in GH secretion was thought to be a D 2 -type receptor, whereas D 1 receptors are believed to be involved in prolactin secretion (Fabbrini et al., 1988) . The reduction in postsynapticdopamine-D 2 -receptor sensitivity in alcoholics who had been abstaining from alcohol for ≥8 days might be a trait marker for alcoholism. This may be consistent with the dopaminergic hypothesis of alcoholism (Eckardt et al., 1998; Koob et al., 1998; Ikemoto and Panksepp, 1999) . It may also account for the fact that, prior to detoxification, active alcoholics exhibit a reduced prolactin response to the antagonist haldol. This response reverted to control values 13 days after detoxification (Markianos et al., 2000) .
Baseline studies of HVA found that alcoholics had lower levels of this metabolite in their plasma than did control subjects (Fulton et al., 1995) . However, the HVA levels found in the CSF of alcoholics and in the plasma of male COA were similar to those found in controls (Roy et al., 1990; Limson et al., 1991; Howard et al., 1996; George et al., 1999; Petrakis et al., 1999) . Early-onset alcoholics were found to have lower levels of HVA in their CSF than late-onset alcoholics (FilsAime et al., 1996) . These results were contradicted by other studies, however, which found increased CSF HVA levels in early-onset alcoholics relative to late-onset alcoholics (George et al., 1999; Petrakis et al., 1999) .
In conclusion, these inconsistent baseline studies show that the changes in dopaminergic neurotransmission that are associated with alcoholism do not appear to fulfil either of the reviewed criteria for a trait marker of alcoholism. The challenge studies in alcoholics who had been abstaining for a protracted period of time showed a decreased dopamine receptor response that seems to fulfil one of the criteria for a trait marker, namely that it is present in alcoholics (Tables 1 and 4 ).
NORADRENALINE
Pharmacological properties
Noradrenaline acts on various adrenergic receptors (two α receptors and two β receptors), all of which are G-protein coupled. The α 1 adrenergic receptor is linked to the mobilization of intracellular calcium by phospholipase C, whereas the α 2 adrenergic receptor inhibits adenylyl cyclase. The β 1 and β 2 adrenergic receptors stimulate adenylyl cyclase. A major metabolite of noradrenaline is 3-methoxy-4-hydroxyphenylglycol.
Research findings
Reduced numbers of melanin-containing noradrenergic neurons were found in the post-mortem locus coeruleus of alcoholics, which indicates a lower level of noradrenergic neurotransmission (Arango et al., 1994) . This was inconsistent with the findings of Baker et al., (1994) , however, which showed no differences post-mortem. In a baseline study, CSF and plasma were continuously sampled in controls and in alcoholics who had been abstaining for 38-124 days (Geracioti et al., 1994) . The results showed that CSF (Roy et al., 1990; Limson et al., (Balldin et al., 1992; Dettling et al., 1995) 1991; George et al., 1999; Petrakis et al., 1999 ) (long-term abstinence) Alcoholics vs controls:
Alcoholics vs controls: Increased GH response to dopamine infusion Decreased HVA plasma levels (Fulton et al., 1995 ) (Annuziato et al., 1983 ) (short-term abstinence) Alcoholics vs controls:
COA vs controls: Indifferent GH response to apomorphine Indifferent HVA plasma levels (Howard et al., 1996) (Balldin et al., 1985) (short-term abstinence) Alcoholics vs controls:
Early-onset vs late-onset alcoholics: Decreased prolactin response to haldol during Decreased CSF HVA levels alcohol intake, indifferent response after (Fils-Aime et al., 1996) detoxification (Markianos et al., 2000) Early-onset vs late-onset alcoholics: Increased CSF HVA levels (George et al., 1999; Petrakis et al., 1999) noradrenaline was lower in alcoholics than in controls, which was consistent with the findings of Arango et al. (1994) . Although there were no differences in terms of the noradrenaline levels in plasma (Geracioti et al., 1994) , alcoholics were found to have a lower basal level relative to controls (Ehrenreich et al., 1997) . The same study reported that, following a challenge with human CRF or a stress test, the noradrenaline response was unaffected (Ehrenreich et al., 1997) . In addition, alcoholics were found to have a blunted GH response to clonidine (an α 2 adrenergic receptor agonist) in comparison to controls. The effect was found shortly after detoxification and also after 6 months of abstinence (Glue et al., 1989; Berggren et al., 2000) . Similarly, in comparison to controls, alcoholics were found to have an enhanced cortisol response to yohimbine (an α 2 adrenergic receptor antagonist). This reflects the downregulation of postsynaptic noradrenergic receptors that is observed in alcoholics (Krystal et al., 1996) .
In conclusion, both the basal studies of decreased noradrenaline levels in CSF (but not in plasma) and the challenge studies of receptor responsiveness showed that a decrease in noradrenergic neurotransmission seems to fulfil one criterion for a trait marker, that it should be present in alcoholics (Tables 1 and 5 ).
β-ENDORPHIN
Pharmacological properties
Opioids act on three major classes of opiate receptors: µ, δ and κ. These G-protein-coupled receptors, which inhibit adenylyl cyclase, are distributed throughout the CNS. The distribution of β-endorphin, however, is somewhat restricted. It is primarily confined to neurons in the hypothalamus, which send projections to the periaqueductal grey region and to noradrenergic nuclei in the brain stem.
Research findings
Baseline studies in humans have shown that, in individuals at risk of alcoholism, the basal activity level of the endogenous opioid system might be lower than in individuals with a low risk of alcoholism (Volpicelli et al., 1990) . Such a finding would be consistent with the opioid-deficiency hypothesis. This was supported by the fact that the β-endorphin levels in the plasma and CSF of alcoholics were lower than those found in controls (Genazzani et al., 1982; Aguirre et al., 1990) . It was reported in one study that alcohol may have an equally strong effect on the central levels of β-endorphin as it does on peripheral levels (Peterson et al., 1996) . A lower dose of naloxone completely blocked any reduction in synaptic opioid content and/or opioid receptor density in high-risk individuals. This indicates that endogenous hypothalamic opioid activity levels in these individuals are lower than those in low-risk subjects (Wand et al., 1998) . Using a placebo, it was found that cortisol levels in high-risk subjects were higher than in low-risk subjects. This indicates that there is probably no increase in opioid receptor affinity, as this would result in more inhibitory tone, and lower cortisol levels.
With regard to challenge studies, the opioid antagonist naloxone produced higher cortisol and β-endorphin responses in alcoholics than in controls. It also caused alcoholics to reduce their consumption of ethanol (Kemper et al., 1990; O'Malley et al., 1992; Volpicelli et al., 1992) . The ingestion of a moderate dose of ethanol induced a dose-dependent increase in plasma β-endorphin levels in high-risk subjects, but not in low-risk subjects. Although these elevated levels were not produced by the peripheral adrenal cortisol system, the more central pituitary β-endorphin system showed an increased sensitivity to ethanol. This might mediate ethanol's reinforcing effects in high-risk subjects (Gianoulakis et al., 1989 . These baseline and challenge studies are consistent with the opioid-deficiency hypothesis. In a twin study, the inter-individual difference in β-endorphin response to alcohol was found to be heritable (Froehlich et al., 2000) .
In conclusion, the measurement of decreased β-endorphin baseline activity appears to fulfil two of the reviewed criteria for a trait marker of alcoholism. These are lower β-endorphin levels in alcoholics and decreased opioid receptor density in COA. However, the measurement of increased β-endorphin responsiveness seems to fulfil three such criteria in that it is heritable, it is present in alcoholics and it is state independent (present in COA). (Tables 1 and 6 ). (Arango et al., 1994) CRF or a stress test (Geraciotti et al., 1994; Ehrenreich et al., 1997) 
Alcoholics vs controls:
Alcoholics vs controls: Alcoholics vs controls: Indifferent number of noradrenergic Increased cortisol response to Indifferent levels of noradrenaline neurons in locus ceruleus (Baker antagonist yohimbine (Krystal in plasma (Geraciotti et al., 1994 Alcoholics vs controls: Alcoholics vs controls: Decreased growth hormone Decreased levels of noradrenaline response to agonist clonidine in plasma (Ehrenreich et al., 1997) (Glue et al., 1989; Berggren et al., 2000) GENERAL CONCLUSIONS AND COMMENTS The present report reviewed five neurotransmitters: GABA, serotonin, dopamine, noradrenaline and β-endorphin (see Table 1 ). Two possible neurochemical markers seemed to fulfil the three reviewed criteria of a trait marker of alcoholism. The first possible marker is the measurement of increased baseline activity of the serotonin transporter in platelets. This is heritable, and is present in both long-term abstinent alcoholics and in COA. The second possible marker is the measurement of increased responsiveness of the pituitary β-endorphin system to challenges. This is heritable, and is present in both alcoholics and COA. Both possible neurochemical markers have yet to be assessed in family cosegregation studies to determine whether the marker segregates with alcoholism within families, to prevent falsepositive conclusions.
It can be concluded from the GABA challenge studies in alcoholics and in COA that the measurement of decreased responsiveness in GABA neurotransmission fulfils two of the reviewed criteria for a trait marker: it is present in both alcoholics and in COA. Further studies on the question of heritability are needed. Another possible trait marker is the measurement of reduced baseline GABA levels in plasma. Its properties must be further studied in COA, to assess the state independence of these effects.
Studies on serotonin activity in alcoholics and COA have shown that increases in serotonin transporter activity can be masked by the recent consumption of alcohol, which may lead to a decrease in serotonin transporter activity in active and newly abstinent alcoholics. This may also hold true for the use of challenge studies to determine the presence of a decreased postsynaptic-serotonin-receptor response in alcoholics, versus an elevated response in COA. The serotonin post-mortem studies that have been reviewed also showed decreased binding to the serotonin transporter and receptor. This may be consistent with a masking effect produced by alcohol (Menninger et al., 1998) .
Although the challenge and baseline studies of dopamine activity in alcoholics produced contradictory results, decreased receptor reactivity was found in alcoholics who had been abstaining for a protracted period of time. The measurement of dopamine levels in plasma poses certain problems; however the use of neuro-imaging techniques (which measure central dopaminergic functions) holds considerable promise for the future.
Indices of changes in the noradrenaline system all corresponded to a fall in noradrenaline baseline levels, and to a reduction in postsynaptic-α 2 -adrenergic-receptor reactivity. There may be reduced activity in the noradrenaline system, of which the assessment might represent a trait marker for alcoholism. However, further studies are required on the presence of these possible markers in COA, and on their heritability.
The reduced baseline level of β-endorphin in alcoholics, together with reduced opioid receptor density in COA and an elevated β-endorphin response to alcohol and naloxone in alcoholics and COA, might be consistent with the opioiddeficiency hypothesis. The finding that inter-individual differences in challenged β-endorphin levels are heritable suggests that the measurement of increased responsiveness of the β-endorphin system may be a trait marker for alcoholism.
In the course of producing this review, no familial cosegregation studies were found on possible neurochemical trait markers and alcoholism. Such studies would have been of use in addressing the issue of possible false-positive conclusions. However, many familial and population-based linkage studies have been carried out into candidate, neurochemistryrelated, alcoholism genes. The Collaborative Study of the Genetics of Alcoholism (COGA) has performed linkage analyses in a large number of families with severe alcoholism. The COGA is a multicentre study for the detection and characterization of genes that influence susceptibility to alcohol dependence and related phenotypes. Data from COGA have been used to study the linkage of vulnerability for alcoholism on regions of chromosomes 1, 2 and 7 (Reich et al., 1998) . Neurogenetic candidate genes on chromosomes 4 and 11 have been reported in a genome-wide scan for genetic linkage to alcohol dependence in a South-western American Indian Tribe (Long et al., 1998) . The regions in question are those near the β 1 GABA receptor gene on chromosome 4, and near the tyrosine hydroxylase and dopamine D 4 receptor genes on chromosome 11.
Genome-wide screenings must be followed by investigations in alcoholics and COA, to determine whether the candidate gene has a real causal relationship with the development of alcoholism over time. As pointed out in the review by Rutter (1994) , it is essential that the component of a multidimensional phenotype of alcoholism be accurately defined Decreased opioid receptor density (Volpicelli et al., 1992 ) (Wand et al., 1998) 
COA vs controls:
Increased β-endorphin response to alcohol (Gianoulakis et al., 1989 and that it be strongly homogeneous in genetic terms. This indicates that further research is needed on the aetiological heterogeneity, mode of transmission and incomplete penetrance of the genes involved in alcoholism (Devor et al., 1994) .
In conclusion, this review presents three main items. First, two possible neurochemical markers fulfil three criteria of a trait marker for alcoholism. The markers in question are the measurements of increased baseline activity of the serotonin transporter in platelets and increased responsiveness of the pituitary β-endorphin system to challenges. Secondly, a description of changes in GABA, dopamine and noradrenaline neurotransmitter systems is presented. As yet, however, these do not fulfil all three reviewed criteria for a trait marker of alcoholism. Thirdly, we would like to emphasize that the use of high-risk groups is essential (a view supported by the many inconsistent studies in COA). Such an approach facilitates investigations into the state independence of a trait marker. This is due to the marked influence of alcohol on neurotransmitter systems, which results in state-dependent changes after alcohol use. It also makes it possible to determine (preferably by the use of longitudinal data) whether an index of a change within a neurotransmitter system has a causal relationship with the development of alcoholism. If so, this would mean that it could serve as a trait marker. Trait markers for alcoholism which do not yet fulfil all of the criteria may do so in the future, once they have been more extensively studied.
